ImmuneSensor Therapeutics

ImmuneSensor Therapeutics is a biotechnology company founded in 2019 and based in Dallas, Texas. It focuses on developing innovative medicines aimed at treating cancer and autoimmune diseases by harnessing the body's innate immune system. The company specializes in creating therapies that target specific pathways to modulate innate immunity, enhancing anticancer responses while also providing inhibitors to manage excessive autoimmune reactions. By utilizing stimulators of interferon gene activators, ImmuneSensor Therapeutics aims to activate the immune defense mechanisms in response to pathogens, cellular stress, and damaged tumor cells, contributing to advancements in immune-mediated therapies.